160 related articles for article (PubMed ID: 23583006)
1. Low molecular weight heparin in patients undergoing free tissue transfer following head and neck ablative surgery: review of efficacy and associated complications.
Eley KA; Parker RJ; Watt-Smith SR
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):610-4. PubMed ID: 23583006
[TBL] [Abstract][Full Text] [Related]
2. Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps.
Chien W; Varvares MA; Hadlock T; Cheney M; Deschler DG
Laryngoscope; 2005 Jun; 115(6):973-6. PubMed ID: 15933503
[TBL] [Abstract][Full Text] [Related]
3. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
4. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
[TBL] [Abstract][Full Text] [Related]
5. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
6. Does anticoagulation improve outcomes of microvascular free flap reconstruction following head and neck surgery: a systematic review and meta-analysis.
Dawoud BES; Kent S; Tabbenor O; Markose G; Java K; Kyzas P
Br J Oral Maxillofac Surg; 2022 Dec; 60(10):1292-1302. PubMed ID: 36328862
[TBL] [Abstract][Full Text] [Related]
7. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
Oldgren J; Johnston N; Siegbahn A
Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
[TBL] [Abstract][Full Text] [Related]
9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.
Lim W; Dentali F; Eikelboom JW; Crowther MA
Ann Intern Med; 2006 May; 144(9):673-84. PubMed ID: 16670137
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery.
Douketis JD; Kinnon K; Crowther MA
Thromb Haemost; 2002 Jul; 88(1):37-40. PubMed ID: 12152674
[TBL] [Abstract][Full Text] [Related]
13. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation.
Barbour LA; Oja JL; Schultz LK
Am J Obstet Gynecol; 2004 Sep; 191(3):1024-9. PubMed ID: 15467584
[TBL] [Abstract][Full Text] [Related]
14. Postoperative anticoagulation after free flap reconstruction for head and neck cancer: A systematic review.
Barton BM; Riley CA; Fitzpatrick JC; Hasney CP; Moore BA; McCoul ED
Laryngoscope; 2018 Feb; 128(2):412-421. PubMed ID: 28581030
[TBL] [Abstract][Full Text] [Related]
15. Use of systemic low-dose unfractionated heparin in microvascular head and neck reconstruction: Influence in free-flap outcomes.
Numajiri T; Sowa Y; Nishino K; Arai A; Tsujikawa T; Ikebuchi K; Nakano H; Sakaguchi H
J Plast Surg Hand Surg; 2016 Jun; 50(3):135-41. PubMed ID: 26937948
[TBL] [Abstract][Full Text] [Related]
16. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
17. Dalteparin dosing in high-flux haemodialysis and haemodiafiltration.
Sridharan S; Berdeprado J; Sivalingam M; Farrington K
Nephron Clin Pract; 2012; 122(1-2):53-7. PubMed ID: 23548465
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin dosing and monitoring in solid organ transplant recipients.
Moten MA; Gaber AO; Putney D; Patel SJ
Clin Transplant; 2013; 27(6):852-7. PubMed ID: 24033530
[TBL] [Abstract][Full Text] [Related]
19. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
Frank RD; Brandenburg VM; Lanzmich R; Floege J
Nephrol Dial Transplant; 2004 Jun; 19(6):1552-8. PubMed ID: 15034159
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin.
Lynch AM; deLaforcade AM; Sharp CR
J Vet Emerg Crit Care (San Antonio); 2014; 24(4):421-8. PubMed ID: 25154357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
